Description
The Trends in Therapeutic Partnering
report provides the most comprehensive and in-depth insight into the 35 most
popular therapeutic targets for partnering in the period 2007 to mid 2013.
The report provides a detailed
understanding and analysis of the most popular therapeutic targets for
partnering in the period 2007 to mid 2013. The majority of deals are discovery,
preclinical and clinical stage whereby the licensee obtains a right or an
option right to license or access the licensors compounds or product candidates.
These deals tend to be multicomponent, starting with collaborative R&D, and
commercialization of outcomes.
To
Read the Complete Report with TOC Visit:
http://www.marketresearchreports.biz/analysis-details/trends-in-therapeutic-partnering
One of the key aspects of partnering
is finding those companies that are potential candidates for the development
and commercialization of the next generation of therapeutic targets. A lot of
resources are spent on finding partners, identifying their interests and making
contact to initiate discussions.
Using this report, dealmakers will
effectively and efficiently target their partnering activities to deliver the
company’s business development objectives. Over 300 charts allow quick
understanding of therapeutic partnering trends since 2007, together with
insight into which companies are active in each of the thirty five leading
therapeutic areas.
Understanding the flexibility of a
prospective partner’s negotiated deals terms provides critical insight into the
negotiation process in terms of what you can expect to achieve during the
negotiation of terms. Whilst many smaller companies will be seeking details of
the payments clauses, the devil is in the detail in terms of how payments are
triggered – contract documents provide this insight where press releases and
databases do not.
To Buy The Copy of This Report
Visit : http://www.marketresearchreports.biz/analysis/172528
The initial chapters of this report
provide an orientation of therapeutic dealmaking.
Chapter 1 provides an introduction to the report, whilst
Chapter 2 provides an overview of therapeutic dealmaking since 2007,
listing the top therapeutic areas for partnering by deal frequency and deal
dollars committed by partnering companies.
Chapter 3 reviews the top pharma and biotech therapeutic partnering
deals of 2007-2013 according to reported deal size.
Contact
M/s Sheela
90 Sate Street, Suite
700
Albany, NY 12207
USA – Canada Toll Free:
866-997-4948
Blog:
http://industry-research-reports.blogspot.com/
No comments:
Post a Comment